Skip to Main Content

Stephen Hahn, President Trump’s nominee to helm the Food and Drug Administration, will today face his first real test in Washington — a confirmation hearing packed with hours of questions from senators on nearly every aspect of the agency’s sprawling portfolio, from mysterious vaping illnesses to the promise of gene therapies.

Hahn, who currently serves as the chief medical executive of MD Anderson Cancer Center, is auditioning for the FDA’s top job at a transformational time for the agency.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • I’ have been posting for several years that FDA has been totally unwilling to use its authority to regulate vaping device safety, impose nicotine purity and dosage levels, and make a gesture to ban the sale of devices designed for vaping illicit drugs. As a consequence we have seen needless illness and death – but only in the USA where we have “free markets” (an oxymoron if there ever was one).

Comments are closed.